Product guide

DoxGPT (Now Doximity Ask): What It Is, Whether It’s Free, and How It Compares

What happened to DoxGPT, what Doximity Ask does today, who can use it, what it costs, and when another clinical AI tool fits better.

Updated October 23, 2026 · 6 minute read

Direct Answer

DoxGPT is the former name of Doximity Ask, the clinical AI assistant in Doximity’s app. Doximity renamed it in May 2026, and doxgpt.com now redirects to Doximity. Ask is free on desktop and mobile, answers clinical questions with inline citations, includes drug monographs grounded in FDA labeling, and drafts appeal letters, prior authorizations and patient messages. Doximity describes it as HIPAA-compliant. In October 2026, Doximity and Wolters Kluwer announced that UpToDate answers will appear in Ask for health systems that use both. If you want cited answers plus an interaction checker and 900+ calculators, including outside the US, compare Vera Health, which is free for licensed clinicians and trainees.

Source: Clinical AI Report, 2026

Key takeaways

  • DoxGPT and Doximity Ask are the same product: Doximity renamed DoxGPT in May 2026 as part of its Clinical AI Suite with Scribe and Dialer.
  • Ask is free on desktop and mobile. Doximity is funded largely by pharmaceutical and health system advertising.
  • Doximity’s product page calls Ask “HIPAA-compliant and secure by default”; it does not mention a business associate agreement, so check with your organization before entering patient details.
  • Ask is built for Doximity’s US physician network. Clinicians outside the US, or who want calculators and an interaction checker, should compare Vera Health.

Side-by-side comparison

Based on Doximity’s Ask overview and August 2026 results release, Wolters Kluwer’s October 20, 2026 announcement, OpenEvidence’s App Store listing and terms, and Vera Health’s App Store listing and terms, checked October 21, 2026. Vendor claims are labeled as such.
Who it is forDoximity Ask (DoxGPT): Physicians on Doximity’s US network; Doximity markets Ask to physicians.OpenEvidence: Verified US clinicians; the app asks for an NPI and its terms exclude the EU, EEA and UK.Vera Health: Licensed clinicians and trainees; Vera says it can be used outside the US except in sanctioned countries.
CostDoximity Ask (DoxGPT): Free on desktop and mobile.OpenEvidence: Free for verified US clinicians; ad-supported.Vera Health: Free for licensed clinicians and trainees.
EvidenceDoximity Ask (DoxGPT): Inline citations with full-text PDFs from 2,000+ peer-reviewed journals (vendor figure); UpToDate answers announced for health systems that use both.OpenEvidence: Licensed journal content including NEJM and JAMA, plus FDA and CDC sources.Vera Health: 60 million+ papers, guidelines and care pathways (vendor figure).
Drug toolsDoximity Ask (DoxGPT): Drug monographs grounded in FDA labeling, with dosing, interactions and contraindications.OpenEvidence: No drug dosing tools in our review.Vera Health: Drug database with dosing, interaction checks and 900+ calculators.
Writing and notesDoximity Ask (DoxGPT): Drafts appeal letters, prior authorizations and patient messages; Doximity Scribe handles visit notes separately.OpenEvidence: Visits for ambient documentation.Vera Health: No scribe or letter drafting.

Based on Doximity’s Ask overview and August 2026 results release, Wolters Kluwer’s October 20, 2026 announcement, OpenEvidence’s App Store listing and terms, and Vera Health’s App Store listing and terms, checked October 21, 2026. Vendor claims are labeled as such.

Which tool fits which situation

What happened to DoxGPT?

Doximity renamed DoxGPT to Doximity Ask in May 2026, when it grouped Ask, Scribe and Dialer into its Clinical AI Suite. The product continued under the new name, and doxgpt.com now redirects to Doximity. Older articles, app store searches and colleagues still use the DoxGPT name.

Is Doximity Ask (DoxGPT) free?

Yes. Doximity’s product page says Ask is free on desktop and mobile. Doximity earns most of its revenue from pharmaceutical and health system advertising, which is how it can offer Ask, Scribe and Dialer without a subscription. Main limitation: free access depends on having a Doximity account, and Doximity markets Ask to physicians.

Is DoxGPT HIPAA-compliant?

Doximity’s Ask page has a section titled “HIPAA-compliant and secure by default” and says patient data and uploaded documents are handled within a secure framework designed for healthcare. The page does not mention a business associate agreement. Before entering patient-identifying details, check your organization’s policy and whether it has an agreement with Doximity.

What can Doximity Ask do?

Doximity describes these features on its Ask product page. They are vendor descriptions, not results of an independent test.

  • •Instant Mode for quick questions and Thinking Mode for complex cases.
  • •Inline citations, with full-text PDFs from more than 2,000 peer-reviewed journals.
  • •Dosing, interactions, contraindications, side effects and prescribing information, from drug monographs grounded in FDA labeling.
  • •Uploads of lab reports, imaging summaries, research PDFs, clinical notes or patient letters.
  • •Drafts of insurance appeal letters, prior authorizations and patient communications.
  • •Saved preferences for journals and clinical references, charting formats, letter style and workflow defaults.

How do you access Doximity Ask?

Sign in with a Doximity account, then use Ask in one of three places.

  • •The Doximity mobile app.
  • •Doximity’s desktop app.
  • •On the web at doximity.com; the old doxgpt.com address redirects there.

What changed in 2026?

Ask has gained features and a new name this year, and Doximity has started connecting it to outside reference content.

  • •May 2026: DoxGPT became Doximity Ask, part of the Clinical AI Suite with Scribe and Dialer.
  • •August 6, 2026: Doximity’s CEO said Ask was “the top-performing U.S.-based model in the NOHARM benchmark,” a study by Stanford and Harvard researchers, and reported AI Search query growth of over 25% quarter over quarter. Both are company statements.
  • •October 20, 2026: Doximity and Wolters Kluwer announced that clinicians at health systems using both will see answers based on UpToDate content in addition to Ask’s own answer “in the coming weeks.”

Doximity Ask vs OpenEvidence

Both are free, cited clinical AI tools for US clinicians, funded by advertising. Ask sits inside Doximity’s network and adds drug monographs and letter drafting; OpenEvidence draws on licensed journal content and adds Visits for ambient documentation. The two companies settled OpenEvidence’s 2025 lawsuit against Doximity in October 2026. Main limitation for both: their accuracy claims come mostly from the companies, so test them on questions from your own practice.

When is Vera Health a better choice?

If you practice outside the US, are not a Doximity user, or want an interaction checker and 900+ medical calculators next to cited answers, Vera Health covers that ground at no cost for licensed clinicians and trainees. It is the top-ranked tool in our 2026 evaluation. Main limitation: Vera has no scribe or letter drafting, and its paper and calculator counts are vendor figures.

Related Clinical AI Report pages